{"schema_version":"secwatch.filing_event.v1","accession":"0001599298-24-000064","form_type":"8-K","ticker":"SMMT","cik":"0001599298","company_name":"Summit Therapeutics Inc.","filed_at":"2024-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.156767+00:00","generated_at":"2026-06-04T00:04:34.763252+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Summit Therapeutics appoints Dr. Mostafa Ronaghi to board of directors","bullets":["Dr. Ronaghi elected to board and Compensation Committee effective April 11, 2024.","Received option grant per non-employee director compensation policy; indemnification agreement.","Former CTO and SVP at Illumina (2008-2021); co-founded GRAIL in 2016.","Summit CEO cites Ronaghi's expertise in genomics to help maximize ivonescimab potential."],"urls":{"canonical":"https://secwatch.observer/filing/0001599298-24-000064","json":"https://secwatch.observer/filing/0001599298-24-000064.json","markdown":"https://secwatch.observer/filing/0001599298-24-000064.md","text":"https://secwatch.observer/filing/0001599298-24-000064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000064/0001599298-24-000064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000064/smmt-20240411.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T00:04:34.763252+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6e91abf4a5","claim":"Mostafa Ronaghi was appointed as Director at Summit Therapeutics Inc..","evidence_excerpt":"the board of directors (the “Board”) of Summit Therapeutics Inc. (the “Company”) unanimously approved the election of Mostafa Ronaghi, PhD, as a director of the Company and the appointment of Dr. Ronaghi to serve on the Compensation Committee of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000064/0001599298-24-000064-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}